These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 12050928)
1. Development of a monitoring system for heroin-assisted substitution treatment in Switzerland. Gschwend P; Rehm J; Lezzi S; Blättler R; Steffen T; Gutzwiller F; Uchtenhagen A Soz Praventivmed; 2002; 47(1):33-8. PubMed ID: 12050928 [TBL] [Abstract][Full Text] [Related]
2. [8 years experience with heroin-assited treatment in Switzerland--current results and future improvements]. Gschwend P; Eschmann S; Güttinger F; Hosek M; Rehm J; Uchtenhagen A Ther Umsch; 2003 Jun; 60(6):355-60. PubMed ID: 12848072 [TBL] [Abstract][Full Text] [Related]
3. Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study. Gschwend P; Rehm J; Blättler R; Steffen T; Seidenberg A; Christen S; Bürki C; Gutzwiller F Eur Addict Res; 2004; 10(1):41-8. PubMed ID: 14665805 [TBL] [Abstract][Full Text] [Related]
4. [Heroin-assisted treatment of opioid addicts in Switzerland from 1994-2001--utilisation and characteristics of admissions and discharges]. Gschwend P; Rehm J; Eschmann S; Uchtenhagen A Gesundheitswesen; 2003 Feb; 65(2):75-80. PubMed ID: 12632315 [TBL] [Abstract][Full Text] [Related]
5. [Co-morbidity: psychiatric disorder of opiate addicts at entry into heroin-assisted treatment]. Frei A; Rehm J; Psychiatr Prax; 2002 Jul; 29(5):251-7. PubMed ID: 12101491 [TBL] [Abstract][Full Text] [Related]
6. Evaluating long-term effects of heroin-assisted treatment: the results of a 6-year follow-up. Güttinger F; Gschwend P; Schulte B; Rehm J; Uchtenhagen A Eur Addict Res; 2003 Apr; 9(2):73-9. PubMed ID: 12644733 [TBL] [Abstract][Full Text] [Related]
7. Heroin-assisted treatment in Switzerland: a case study in policy change. Uchtenhagen A Addiction; 2010 Jan; 105(1):29-37. PubMed ID: 19922519 [TBL] [Abstract][Full Text] [Related]
8. [Heroin-assisted treatment of opiate dependent patients. Experiences from Swiss trials for medical prescription of narcotics (PROVE)]. Steffen T; Uchtenhagen A; Gutzwiller F; Dobler-Mikola A; Blättler R Internist (Berl); 1999 Jun; 40(6):651-6. PubMed ID: 10420321 [No Abstract] [Full Text] [Related]
9. Heroin prescription in Europe: heroin treatment is a pragmatic way of reducing the risks associated with addiction. Prescrire Int; 2003 Dec; 12(68):235-6. PubMed ID: 14986702 [No Abstract] [Full Text] [Related]
10. Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients. Backmund M; Meyer K; Eichenlaub D; Schütz CG Drug Alcohol Depend; 2001 Oct; 64(2):173-80. PubMed ID: 11543987 [TBL] [Abstract][Full Text] [Related]
11. Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Rehm J; Gschwend P; Steffen T; Gutzwiller F; Dobler-Mikola A; Uchtenhagen A Lancet; 2001 Oct; 358(9291):1417-23. PubMed ID: 11705488 [TBL] [Abstract][Full Text] [Related]
12. The response of out-patient opiate addicts to the provision of a temporary increase in their prescribed drugs. Gossop M; Strang J; Connell PH Br J Psychiatry; 1982 Oct; 141():338-43. PubMed ID: 7171908 [TBL] [Abstract][Full Text] [Related]
13. [Development of skin diseases in intravenous drug dependent patients treated with heroin substitution]. Conrad C; Steffen T; Gutzwiller F Praxis (Bern 1994); 2000 Nov; 89(46):1899-906. PubMed ID: 11111408 [TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors from a long-term follow-up of heroin-assisted treatment in Switzerland 1994-2007]. Frick U; Wiedermann W; Schaub M; Uchtenhagen A; Rehm J Psychiatr Prax; 2010 May; 37(4):175-82. PubMed ID: 20148381 [TBL] [Abstract][Full Text] [Related]
15. [Problems in the detoxication of narcotic addicts]. Täschner KL; Pittrich-Fahl U Ther Ggw; 1981 Apr; 120(4):334-42. PubMed ID: 7233350 [No Abstract] [Full Text] [Related]
17. Opioid substitution treatment reduces substance use equivalently in patients with and without posttraumatic stress disorder. Trafton JA; Minkel J; Humphreys K J Stud Alcohol; 2006 Mar; 67(2):228-35. PubMed ID: 16562404 [TBL] [Abstract][Full Text] [Related]
18. Mortality in heroin-assisted treatment in Switzerland 1994-2000. Rehm J; Frick U; Hartwig C; Gutzwiller F; Gschwend P; Uchtenhagen A Drug Alcohol Depend; 2005 Aug; 79(2):137-43. PubMed ID: 16002023 [TBL] [Abstract][Full Text] [Related]
19. Availability of drugs and psychological proneness in opioid addiction. Barrett ME; Joe GW; Simpson DD Int J Addict; 1990 Oct; 25(10):1211-26. PubMed ID: 2090624 [TBL] [Abstract][Full Text] [Related]
20. The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) project: an open-label pragmatic randomised control trial comparing the efficacy of differing therapeutic agents for primary care detoxification from either street heroin or methadone [ISRCTN07752728]. Oldham NS; Wright NM; Adams CE; Sheard L; Tompkins CN BMC Fam Pract; 2004 Apr; 5():9. PubMed ID: 15117415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]